Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [1043]

Epigenetic therapy shows promise for endocrine-resistant breast cancer

Epigenetic therapy shows promise for endocrine-resistant breast cancer

Studies help explain why some prostate cancers become resistant to hormone therapy

Studies help explain why some prostate cancers become resistant to hormone therapy

SABCS 2023: Younger postmenopausal patients with early-stage breast cancer may be able to safely omit adjuvant radiotherapy

SABCS 2023: Younger postmenopausal patients with early-stage breast cancer may be able to safely omit adjuvant...

SABCS 2023: Tucatinib plus trastuzumab emtansine may benefit patients with advanced or metastatic HER2-positive breast cancer

SABCS 2023: Tucatinib plus trastuzumab emtansine may benefit patients with advanced or metastatic HER2-positive...

Research finds correlation between biomarker HSD3B1 and resistance to combined hormone therapy and radiotherapy

Research finds correlation between biomarker HSD3B1 and resistance to combined hormone therapy and radiotherapy

187 new genetic variants linked to prostate cancer

187 new genetic variants linked to prostate cancer

Aid agencies are failing patients with BC in war zones meaning more will develop advanced disease

Aid agencies are failing patients with BC in war zones meaning more will develop advanced disease

FDA amends pembrolizumab’s gastric cancer indication

FDA amends pembrolizumab’s gastric cancer indication

People with advanced breast cancer are forced out of work with a cost to themselves and the economy

People with advanced breast cancer are forced out of work with a cost to themselves and the economy

PHOEBE trial results show patients with advanced HER2-positive BC live longer on pyrotinib

PHOEBE trial results show patients with advanced HER2-positive BC live longer on pyrotinib

More from ecancer